Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Elizabet Tavitian
8  Ergebnisse:
Personensuche X
?
1

Association of patient activity bio-profiles with health-re..:

Korde, Neha ; Tavitian, Elizabet ; Mastey, Donna...
eClinicalMedicine.  57 (2023)  - p. 101854 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Tailored treatment to MRD response: A phase I/II study for ..:

Korde, Neha ; Mastey, Donna ; Tavitian, Elizabet...
American Journal of Hematology.  96 (2021)  6 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
3

Minimal residual disease negativity in multiple myeloma is ..:

Pianko, Matthew J. ; Devlin, Sean M. ; Littmann, Eric R....
Blood Advances.  3 (2019)  13 - p. 2040-2044 , 2019
Link: https://doi.org/10.1182/..
 
?
4

Association of patient activity bio-profiles with health-re..:

Neha Korde ; Elizabet Tavitian ; Donna Mastey...
http://www.sciencedirect.com/science/article/pii/S2589537023000317.  , 2023
Link: https://doi.org/10.1016/..
 
?
5

Association of patient activity bio-profiles with health-re..:

Korde, Neha ; Tavitian, Elizabet ; Mastey, Donna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989635/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Safety and Effectiveness of Weekly Carfilzomib, Lenalidomid..:

Landgren, Ola ; Hultcrantz, Malin ; Diamond, Benjamin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050789/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Tailored treatment to MRD response: A phase I/II study for ..:

Korde, Neha ; Mastey, Donna ; Tavitian, Elizabet...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251553/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Minimal residual disease negativity in multiple myeloma is ..:

Pianko, Matthew J ; Devlin, Sean M ; Littmann, Eric R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616258/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-8